ATE362919T1 - Lactamverbindungen - Google Patents
LactamverbindungenInfo
- Publication number
- ATE362919T1 ATE362919T1 AT01996530T AT01996530T ATE362919T1 AT E362919 T1 ATE362919 T1 AT E362919T1 AT 01996530 T AT01996530 T AT 01996530T AT 01996530 T AT01996530 T AT 01996530T AT E362919 T1 ATE362919 T1 AT E362919T1
- Authority
- AT
- Austria
- Prior art keywords
- lactam compounds
- lactam
- compounds
- Prior art date
Links
- -1 LACTAM COMPOUNDS Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyrrole Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24965600P | 2000-11-17 | 2000-11-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE362919T1 true ATE362919T1 (de) | 2007-06-15 |
Family
ID=22944436
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01996530T ATE362919T1 (de) | 2000-11-17 | 2001-11-02 | Lactamverbindungen |
Country Status (33)
| Country | Link |
|---|---|
| US (1) | US20040248878A1 (OSRAM) |
| EP (1) | EP1353910B1 (OSRAM) |
| JP (1) | JP4116431B2 (OSRAM) |
| KR (1) | KR20030045194A (OSRAM) |
| CN (2) | CN101624372A (OSRAM) |
| AR (1) | AR031356A1 (OSRAM) |
| AT (1) | ATE362919T1 (OSRAM) |
| AU (2) | AU2432102A (OSRAM) |
| BR (1) | BR0115424A (OSRAM) |
| CA (1) | CA2425497C (OSRAM) |
| CY (1) | CY1106682T1 (OSRAM) |
| CZ (1) | CZ20031340A3 (OSRAM) |
| DE (1) | DE60128587T2 (OSRAM) |
| DK (1) | DK1353910T3 (OSRAM) |
| DZ (1) | DZ3454A1 (OSRAM) |
| EA (1) | EA006919B1 (OSRAM) |
| EC (1) | ECSP034598A (OSRAM) |
| ES (1) | ES2286162T3 (OSRAM) |
| HR (1) | HRP20030385A2 (OSRAM) |
| HU (1) | HUP0301862A3 (OSRAM) |
| IL (1) | IL155275A0 (OSRAM) |
| MX (1) | MXPA03004250A (OSRAM) |
| MY (1) | MY141607A (OSRAM) |
| NO (1) | NO325217B1 (OSRAM) |
| PE (1) | PE20020798A1 (OSRAM) |
| PL (1) | PL211018B1 (OSRAM) |
| PT (1) | PT1353910E (OSRAM) |
| SK (1) | SK287794B6 (OSRAM) |
| SV (1) | SV2003000741A (OSRAM) |
| TW (1) | TWI235151B (OSRAM) |
| UA (1) | UA77165C2 (OSRAM) |
| WO (1) | WO2002040451A2 (OSRAM) |
| ZA (1) | ZA200303411B (OSRAM) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA74849C2 (en) * | 2000-11-17 | 2006-02-15 | Lilly Co Eli | Lactam |
| CA2509413C (en) | 2002-12-20 | 2012-05-01 | Glaxo Group Limited | Benzazepine derivatives for the treatment of neurological disorders |
| DE602004009295T2 (de) | 2003-01-14 | 2008-07-03 | Arena Pharmaceuticals, Inc., San Diego | 1,2,3-trisubstituierte aryl- und heteroarylderivate als modulatoren des metabolismus zur vorbeugung und behandlung von metabolismus-bedingten krankheiten wie diabetes oder hyperglykämie |
| AR045047A1 (es) | 2003-07-11 | 2005-10-12 | Arena Pharm Inc | Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos |
| RU2404968C2 (ru) | 2005-04-08 | 2010-11-27 | Дайити Санкио Компани, Лимитед | Пиридилдиметилсульфоновое производное |
| EP1985615A4 (en) | 2006-01-31 | 2011-12-14 | Api Corp | PROCESS FOR THE PREPARATION OF BENZAZEPINONE |
| TW200920362A (en) | 2007-09-11 | 2009-05-16 | Daiichi Sankyo Co Ltd | Alkylsulfone derivatives |
| FR2932800B1 (fr) * | 2008-06-20 | 2015-02-20 | Servier Lab | Nouveau procede de synthese de la 7,8-dimethoxy-1,3-dihydro- 2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable |
| PH12013500547A1 (en) | 2010-09-22 | 2013-06-10 | Arena Pharm Inc | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
| KR101899014B1 (ko) | 2012-01-06 | 2018-09-17 | 삼성전자주식회사 | 비엘디씨 모터의 제어 장치 및 그 방법 |
| CN102690231B (zh) * | 2012-04-11 | 2014-07-09 | 南京友杰医药科技有限公司 | 治疗阿尔茨海默病潜在药物司马西特的合成方法 |
| EP2987496B1 (en) | 2013-04-19 | 2018-08-08 | National University Corporation Okayama University | Treatment agent for cognitive disorders, induced by amyloid -protein, therapeutic agent for alzheimer's disease, and treatment method and pathological analysis method related to these |
| ES2995737T3 (en) | 2015-01-06 | 2025-02-11 | Arena Pharm Inc | Compound for use in treating conditions related to the s1p1 receptor |
| MA42807A (fr) | 2015-06-22 | 2018-07-25 | Arena Pharm Inc | Sel l-arginine cristallin d'acide (r)-2-(7-(4-cyclopentyl-3-(trifluorométhyl)benzyloxy)-1,2,3,4-tétrahydrocyclo-penta[b]indol-3-yl)acétique (composé 1) pour une utilisation dans des troubles associés au récepteur de s1p1 |
| WO2018151873A1 (en) | 2017-02-16 | 2018-08-23 | Arena Pharmaceuticals, Inc. | Compounds and methods for treatment of primary biliary cholangitis |
| EP3801459B1 (en) | 2018-06-06 | 2024-08-07 | Arena Pharmaceuticals, Inc. | Methods of treating conditions related to the s1p1 receptor |
| EP4126952A1 (en) | 2020-03-26 | 2023-02-08 | Seagen Inc. | Methods of treating multiple myeloma |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3812952B2 (ja) * | 1996-12-23 | 2006-08-23 | エラン ファーマシューティカルズ，インコーポレイテッド | シクロアルキル、ラクタム、ラクトンおよびその関連化合物およびその医薬組成物、並びに該化合物を用いたβ−アミロイドペプチドの放出および／またはその合成を阻害する方法 |
| WO1999067219A1 (en) * | 1998-06-22 | 1999-12-29 | Elan Pharmaceuticals, Inc. | Compounds for inhibiting beta-amyloid peptide release and/or its synthesis |
| AU1569501A (en) * | 1999-11-09 | 2001-06-06 | Eli Lilly And Company | Beta-aminoacid compounds useful for inhibiting beta-amyloid peptide release and/or its synthesis |
-
2001
- 2001-02-11 UA UA2003054406A patent/UA77165C2/uk unknown
- 2001-11-02 CN CN200910203885A patent/CN101624372A/zh active Pending
- 2001-11-02 EP EP01996530A patent/EP1353910B1/en not_active Expired - Lifetime
- 2001-11-02 PL PL360991A patent/PL211018B1/pl unknown
- 2001-11-02 CZ CZ20031340A patent/CZ20031340A3/cs unknown
- 2001-11-02 AU AU2432102A patent/AU2432102A/xx active Pending
- 2001-11-02 MX MXPA03004250A patent/MXPA03004250A/es active IP Right Grant
- 2001-11-02 CN CNB018189962A patent/CN100516047C/zh not_active Expired - Fee Related
- 2001-11-02 DE DE60128587T patent/DE60128587T2/de not_active Expired - Lifetime
- 2001-11-02 BR BR0115424-9A patent/BR0115424A/pt not_active Application Discontinuation
- 2001-11-02 DK DK01996530T patent/DK1353910T3/da active
- 2001-11-02 DZ DZ013454A patent/DZ3454A1/fr active
- 2001-11-02 PT PT01996530T patent/PT1353910E/pt unknown
- 2001-11-02 HU HU0301862A patent/HUP0301862A3/hu unknown
- 2001-11-02 HR HR20030385A patent/HRP20030385A2/hr not_active Application Discontinuation
- 2001-11-02 IL IL15527501A patent/IL155275A0/xx unknown
- 2001-11-02 SK SK543-2003A patent/SK287794B6/sk not_active IP Right Cessation
- 2001-11-02 AT AT01996530T patent/ATE362919T1/de active
- 2001-11-02 AU AU2002224321A patent/AU2002224321B2/en not_active Ceased
- 2001-11-02 US US10/415,548 patent/US20040248878A1/en not_active Abandoned
- 2001-11-02 EA EA200300579A patent/EA006919B1/ru unknown
- 2001-11-02 ES ES01996530T patent/ES2286162T3/es not_active Expired - Lifetime
- 2001-11-02 CA CA2425497A patent/CA2425497C/en not_active Expired - Fee Related
- 2001-11-02 JP JP2002542779A patent/JP4116431B2/ja not_active Expired - Fee Related
- 2001-11-02 KR KR10-2003-7006660A patent/KR20030045194A/ko not_active Ceased
- 2001-11-02 WO PCT/US2001/027795 patent/WO2002040451A2/en not_active Ceased
- 2001-11-15 AR ARP010105339A patent/AR031356A1/es not_active Application Discontinuation
- 2001-11-15 TW TW090128351A patent/TWI235151B/zh not_active IP Right Cessation
- 2001-11-15 MY MYPI20015251A patent/MY141607A/en unknown
- 2001-11-16 SV SV2001000741A patent/SV2003000741A/es unknown
- 2001-11-16 PE PE2001001143A patent/PE20020798A1/es not_active Application Discontinuation
-
2003
- 2003-05-02 ZA ZA200303411A patent/ZA200303411B/en unknown
- 2003-05-13 EC EC2003004598A patent/ECSP034598A/es unknown
- 2003-05-15 NO NO20032215A patent/NO325217B1/no unknown
-
2007
- 2007-06-28 CY CY20071100848T patent/CY1106682T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20032236L (no) | Laktamforbindelse | |
| NO20026196L (no) | Kinazolinditosylatsalt-forbindelser | |
| DK1619192T3 (da) | Arylkondeserede azapolycykliske forbindelser | |
| NO20032585D0 (no) | ABCA-1 forhöyende forbindelser | |
| DK1226127T3 (da) | Substituerede phenylsulfamoylcarboxamider | |
| DE60114153D1 (de) | Substituierte arylpyrazine | |
| AR028393A1 (es) | Iminoazidas substituidas | |
| ATE362919T1 (de) | Lactamverbindungen | |
| PT1268453E (pt) | Metabolitos de agonista/antagonista de estrogenio | |
| DE50112662D1 (de) | Substituierte benzoylcyclohexenone | |
| AR028302A1 (es) | Feniluracilos substituidos | |
| IT250181Y1 (it) | Custodia perfezionata per rivoltella | |
| ATE372338T1 (de) | Deshalogenverbindungen | |
| NO20030303D0 (no) | Kalsilytiske forbindelser | |
| PT1317179E (pt) | Formulacoes de mesotriona | |
| NO20023508D0 (no) | Kalsilyttiske forbindelser | |
| NO20031837D0 (no) | Kalsilytiske forbindelser | |
| MX231963B (es) | Poliamidas | |
| SE0003477D0 (sv) | Compounds | |
| SE0003203D0 (sv) | Novel compounds | |
| SE0003436D0 (sv) | Novel compounds | |
| SE0002331D0 (sv) | Novel compounds | |
| SE0002234D0 (sv) | Novel compounds | |
| SE0000620D0 (sv) | Novel compounds | |
| SE0004824D0 (sv) | Novel compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1353910 Country of ref document: EP |